A yeast two-hybrid screen has identi®ed HBP1 as a transcription factor capable of interacting with the pocket protein family. We show that HBP1 can interact with one of these, RB, both in vitro and in mammalian cells. Two distinct RB binding sites are present within HBP1 ± a high anity binding site, mediated by an LXCXE motif and a separate low anity binding site present within an activation domain. GAL4-fusion experiments indicate that HBP1 contains a masked activation domain. Deletion of two independent N-and C-terminal inhibitor domains unmasks an activation domain which is 100-fold more active than the full length protein. The released activation capacity is repressed by RB, p130 and p107. In addition, E1A can repress the activity of HBP1 via conserved region 1 sequences in a manner independent of the CBP coactivator. We show by stable expression in NIH3T3 cells that HBP1 has the capacity to induce morphological transformation of cells in culture.
Introduction
The pocket proteins, RB, p107, p130, represent a family of transcriptional regulators which have a highly conserved transcription factor-binding`pocket' domain. The prototype of this family, RB, has been found mutated in all Retinoblastomas as well as in many other tumours and this has led to its characterization as a tumour suppressor protein (Weinberg, 1995) . Although p107 and p130 have functions which overlap those of RB, these two genes have not been found to be mutated in tumours. Perhaps, as a consequence, RB still remains the most studied member of this family.
The pocket proteins (most commonly RB) have been shown to bind and regulate a number of dierent transcription factors (Kouzarides, 1995) . Their most characterized target is the E2F family of transcriptional activators, E2F1-5 (Weinberg, 1995) . The three pocket proteins bind and regulate a distinct subset of E2F family members but the reason or mechanism behind this speci®city is not yet clear. The E2F1 protein has the ability to promote G1 to S phase transition by stimulating the activity of S-phase speci®c genes (Nevins, 1992; Johnson et al., 1993) . The binding of RB to E2F1 leads to a suppression of these activation functions, which correlates with RB's ability to induce growth arrest. Only a subset of E2F family members (E2F1, 2, 3) possess the ability to stimulate S-phase. The fact that this subset of E2F proteins is precisely the subset regulated by RB in vivo (rather than p107 or p130) may explain why RB is the only pocket protein mutated in tumours (Lukas et al., 1996) .
Another function of RB which also correlates with its ability to induce growth arrest, is the repression of genes involved in protein biosynthesis. RB can repress most RNA polymerase III (Pol III) transcribed genes in vivo (White et al., 1996) and can regulate RNA polymerase I (pol I) transcription by repressing the UBF transcription factor (Cavanaugh et al., 1995) . Repression of pol I, pol III and E2F regulated pol II genes requires the pocket domain of RB (which is found mutated in tumours) and is alleviated by viral transforming proteins such as E1A binding to RB. The ability of RB to recognize and repress a diverse array of factors which regulate pol I, pol II and pol III genes may be related to the sequence similarity displayed between the RB pocket domain and the two general factors TBP and TFIIB (Hagemeier et al., 1993a) . Although the mechanism of this repression is not yet understood, masking of TBP binding capacity may be involved for both E2F (Hagemeier et al., 1993b) and UBF (Cavanaugh et al., 1995) . However, in addition, RB must contain independent repressive capacity, which acts directly to silence the transcriptional machinery (Weintraub et al., 1992 (Weintraub et al., , 1995 .
A growing body of evidence suggests that RB not only functions to regulate cell proliferation but is also intimately involved in regulating cell dierentiation. Indirect evidence has come from the generation of RB de®cient mice which survive until 14.5 days postcoitum, a time when dierentiation of a number of dierent cell types is known to be initiated (Jacks et al., 1992; Lee et al., 1992; Clarke et al., 1992) . More direct evidence comes from the analysis of RB-interacting proteins (reviewed in Kouzarides, 1995) . A number of these (myoD, C/EBP, Elf1) are transcription factors which have a role in regulating the dierentiation of speci®c cell lineages (Gu et al., 1993; Chen et al., 1996; Wang et al., 1993) . Thus RB may not only regulate the cell cycle, but may also be involved in regulating cell dierentiation.
Here we report that HBP1, an HMG-box transcription factor, is bound and regulated by RB and the other pocket proteins. We show that HBP1 has the capacity to induce morphological transformation of cells in culture and that its transcriptional activation capacity is regulated by the viral E1A protein.
Results
To identify novel targets for pocket proteins, we employed a yeast two-hybrid screen using the pocket domain of p130 (aa 322 ± 1070) as a bait. A library of cDNA's derived from mouse embryos was screened using this bait. This screen identi®ed multiple isolates of an open reading frame from an uncharacterized gene. During our isolation of the mouse full length gene, the full length sequence of the rat homologue was reported by Lesage et al. (1994) . This rat cDNA, designated HBP1 (HMG-Box containing Protein 1) had the features of a transcriptional regulator since it contained a region highly homologous to the HMGbox DNA binding domain. HBP1 is a ubiquitously expressed gene whose expression is stimulated during the dierentiation of adipocytes and muscle cells.
We are con®dent that the mouse HBP1 protein isolated by the two-hybrid screen represented a true p130 interacting target in yeast, for several reasons; (i) it was isolated multiple times from the library; 23 out of 110 clones examined were HBP1. (ii) each of the 23 isolates were overlaps of the same region of HBP1. (iii) all the HBP1 isolates contained the classic LXCXE motif known to mediate interactions with the pocket domain. (iv) the interactions were speci®c since the HBP1 isolates did not interact with a lamin control bait. (v) the E2F1 protein, known to interact with the pocket domain, was also isolated with an identical frequency to HBP1 from the same yeast screen, indicating that our assay was able to recognize true pocket-interacting proteins.
We next tested whether HBP1 speci®cally interacts with p130 or whether HBP1 can recognize other pocket proteins such as RB and p107. Using several assays, it became clear that HBP1 was able to recognize the pocket domain of p130, RB and p107: (1) in the twohybrid assay p130 and RB interact equally well with HBP1 (data not shown), (2) HBP1 can bind RB in vitro and (3) p130, RB and p107 are all capable of repressing the activation functions of HBP1 (see below). Since we could not demonstrate speci®city for any pocket protein, we present here the characterization of the interaction between HBP1 and RB, since this represents the most characterized member of the pocket family.
The HBP1 protein can interact with RB not only in yeast cells but also in mammalian cells. When U20S cells are co-transfected with RB and an HA-tagged version of the rat HBP1, immunoprecipitation of RB co-immunopuri®es HBP1, as recognized by a Western blot with an HA-speci®c antibody ( Figure 1, lane 2) . The RB-speci®c antibody does not immunopurify a control protein (IDP1) tagged with HA (lane 1) and immunoprecipitation with a control antibody (against cyclin B2) does not bring down HA-HBP1 under these conditions (lane 3). Thus RB and HBP1 can form a speci®c complex in mammalian cells.
The HBP1 protein can also interact with RB in vitro. A domain of HBP1 (11 ± 63) which contains the LXCXE motif (LQCNE) linked to GST can interact very eciently with in vitro translated and radiolabelled RB in a GST pull-down assay ( Figure 2) . Mutagenesis of the C and E residues of the LXCXE motif to A residues severely impairs the ability of HBP1 11 ± 63 to bind RB. This result con®rms that the LXCXE motif of HBP1 represents a high anity binding site for RB. HBP1 also contains a second binding site for RB which resides in a region directly C-terminal to the LXCXE motif. A GST fusion linked to residues 37 ± 120 of HBP1 is able to interact with RB, independently of the LXCXE motif, although this interaction is of low anity when compared to the anity of the LXCXE containing HBP 11 ± 63. Thus, GST, GST HBP 11 ± 63, GST HBP 11 ± 63 mut or GST HBP 37 ± 120 were incubated with in vitro translated RB 379 ± 928 and subjected to GST pull down. Precipitated proteins were resolved by SDS ± PAGE, gels were ®xed,¯uorographed, dried then autoradiographed like the E1A protein, HBP1 contains a high and a low anity binding site for RB. The HBP1 protein has the characteristic features of a transcription factor since it contains a domain highly homologous to the HMG-box DNA binding domain. We therefore wanted to know whether HBP1 has the capacity to regulate transcription. Since we did not know the precise DNA binding site for the HBP1 HMG-box, we replaced this DNA binding domain with that of GAL4 and asked whether HBP1 can stimulate transcription from a GAL4-site bearing promoter. Figure 3 shows that a GAL4 fusion with almost the entire HBP1 sequence (GAL4-HBP 11 ± 394) has very weak, but detectable activation capacity relative to GAL4 alone. However, deletion analysis of HBP1 revealed that it contains a very powerful activation domain whose activity is masked by specific inhibitor domains. One of these domains is at the Cterminus of the protein since HBP 11 ± 120 has more than tenfold higher activity than HBP 11 ± 394. A second inhibitor domain resides within the N-terminus of the protein since HBP 37 ± 120 has almost tenfold higher activity than HBP 11 ± 120. Altogether, removal of both the N-and C-terminal inhibitor domains generates an 83 residue activation domain (HBP 37 ± 120) which has 100-fold higher activity than the almost full length HBP 11 ± 394. Further deletion of the activation domain reduces activity but does not abolish it (see HBP 93 ± 120), indicating that the HBP1 activation domain has, like other activation domains, a modular structure composed of several independently activating regions.
We next tested whether the transcriptional activation capacity of HBP1 is regulated by pocket proteins. Figure 4 shows that all three pocket proteins, RB, p130 and p107, can repress the activity of HBP 11 ± 120, which contains both the high and low anity binding sites for RB. Further analysis of RB-mediated repression of HBP1 indicates that this function relies on an intact pocket domain, since a RB pocket mutant, RBD22, is unable to repress the activity of HBP 11 ± 120 ( Figure 5 ). As the LXCXE motif lies outside the HBP1 domain which shows the highest activation capacity (Figure 3) , we asked whether a domain lacking this motif, HBP 37 ± 120, can be repressed by RB. Figure 5 shows that the activation capacity residing within HBP 37 ± 120 is still repressed by RB but less eciently than the domain which contains the high anity LXCXE motif. This repressive capacity is consistent with the presence of a second RB binding site in this domain (Figure 2 ). This repressive eect of RB is speci®c to HBP1 since the activation capacity of Figure 3 HBP1 contains a masked activation domain. Gal 4 fusions of various fragments of HBP1 were generated. 1 mg of Gal4 fusion was transiently transfected into U2OS cells along with 1 mg of 56Gal4 E1bCAT reporter. Thirty-six hours after transfection, cells were harvested, whole cell extracts prepared and CAT assays performed. Activation capacity of HBP1 is de®ned as fold over Gal4 DNA binding domain alone Figure 4 Pocket proteins repress the transcriptional activation capacity of HBP1. U2OS cells were transfected with 1 mg of 56Gal4 E1bCAT reporter and 1 mg of pHKGT HBP 11 ± 120 together with either 500 ng of pCMV neo Bam (7); pCMV RB 379 ± 928 (RB); pCMV p130 (p130) or pCMV p107 (p107). The CAT activity is de®ned relative to HBP 11 ± 120, which was given a value of 100
Figure 5 HBP1 repression by RB is pocket-dependent. U2OS cells were transfected with pHKGT HBP 11 ± 120, pHKGT HBP 37 ± 120 or pHKGT p53 1 ± 73 (1 mg) and 56Gal4 E1b CAT reporter (1 mg) along with either 500 ng pCMV neo Bam (7), pCMV RB 379 ± 928 (RB) or pCMV RBD22 (RBD22). The CAT activity is shown relative to the GAL4 activator control (7) which was given a value of 100 the p53 activation domain is not aected under the same conditions ( Figure 5 ).
The E1A protein is capable of regulating the activity of E2F, another target for the pocket proteins. We therefore asked whether E1A could regulate the activation capacity of HBP1. Figure 6 shows that expression of the E1A 12S product severely inhibits the activation capacity of HBP 11 ± 120. However, E1A was unable to repress the activation capacity of another HMG-box protein, GAL4-mSry (data not shown). Deletion mutants of E1A were then used to map the region of E1A responsible for inhibiting HBP1 functions. Removal of conserved region 2, CR2, (which contains the LXCXE binding site for pocket protein binding) does not aect E1A repression, whereas removal of conserved region 1 (CR1) almost completely abolishes E1A mediated repression. The E1A CR1 region contains binding sites for both RB and CBP. To assess whether binding of these factors was necessary for E1A's ability to repress HBP, we used E1A mutants RB mut and CBP mut which abolish RB and CBP binding respectively (Trouche and . These E1A mutants were perfectly capable of repressing the activity of HBP1 11 ± 120 (Figure 6 ). These results indicate that E1A does not repress HBP1 activity by competing for the CBP co-activator, as it does for c-Fos , and that RB binding is also not involved in this process. The domain of HBP1 which is responsive to E1A mediated repression resides within residues 93 ± 120. The activation of HBP1 93 ± 120 is repressed by E1A in a CR1 dependent manner and once again, this repression does not depend on the binding of CBP and RB (Figure 6 ). These results demonstrate that a small 27 residue region of HBP1 has transcriptional activation capacity which can be repressed by E1A.
To assess the biological functions of HBP1 we cloned an HA tagged version of HBP1 cDNA in a retroviral vector, pBabe-puro, and generated an NIH3T3 cell line (NIHHBP) which expresses the HBP1 protein, as recognized by an HA-speci®c antibody (data not shown). In addition, a control cell line was generated which carried the pBabe-puro vector (NIHpBabe). Microscopic analysis of the two cell lines indicates that the NIHHBP cells are morphologically transformed (Figure 7b ) compared to the control NIHpBabe cells (Figure 7a) . The NIHHBP cells are rounded and elongated compared to the¯attened morphology of the NIHpBabe cells, a feature which is most obvious when the cells are under con¯uent. As the cells become more con¯uent, it becomes apparent that they have lost contact inhibition, forming discrete areas of overgrown cells (Figure 7c ). When the cells become fully con¯uent, the loss of contact inhibition in manifest as discrete foci of morphologically transformed cell (Figure 7d ). Thus, like other targets of RB and E1A, the HBP1 protein has the capacity to induce morphological transformation when overexpressed. 
Discussion
Our analysis of HBP1 indicates that this transcription factor has the capacity to recognize the pocket domains of RB, p130 and p107. This result is consistent with the presence of an LXCXE motif within HBP1, a sequence known to interact with the pocket domain. The interaction between HBP1 and RB can be demonstrated using a number of dierent in vivo and in vitro assays, indicating that this interaction is not due to the fortuitous presence of an LXCXE motif. Further evidence for the biological relevance of these interactions comes from the fact that all three pocket proteins can repress the transcriptional activation capacity of HBP1. Although we cannot exclude the possibility that some selectivity for a certain member of the pocket family is displayed when these proteins are not overexpressed, these experiments at least con®rm that the binding of a pocket protein to HBP1 leads to regulation of its functions.
The HBP1 protein clearly has the potential to activate transcription, but this activity is masked by inhibitor domains. Such inhibitor activity has been described for a number of transcription factors (Gashler et al., 1993; Brown et al., 1995; Nerlov and Zi, 1994; Dubendor et al., 1992) . However, certain features exhibited by HBP1 (its masked activation domain and RB binding characteristics) are very reminiscent of the viral transcription factor E1A (Figure 8) . Firstly, like HBP1, E1A is unable to activate transcription as a full length GAL4 fusion. This is due to an inhibitor domain at the C-terminus of E1A which speci®cally represses the activity of the CR1 activation domain (Sollerbrant et al., 1996) . Secondly, like HBP1, the CR1 activation domain of E1A has a binding site for RB and is repressed by the binding of RB . Thirdly, like HBP1, E1A has a second high anity RB-binding LXCXE motif which falls outside its activation domain and within CR2 (Moran, 1993) . Thus HBP1 is the ®rst characterized transcription factor which has transcriptional activation and RB binding characteristics which resemble those of the viral E1A protein.
The HBP1 protein shares some (but not all) of the properties of the E2F transcription factor. HBP1 has a transcriptional activation domain which is repressed by pocket proteins and has the ability to mediate transformation of cells in culture. However, the proliferative functions of HBP1 must be distinct in nature to those of E2F1 since HBP1 is unable to overtly regulate the cell cycle (data not shown). In addition, our preliminary experiments indicate that HBP1 is unable to relieve RB-induced growth arrest in the¯at cell formation assay. These results suggest that the biological functions of HBP1 are distinct from those of the E2F family. The biological functions of HBP1 may also be related to the process of dierentiation given that HBP1 expression is stimulated during myogenic and adipocyte dierentiation (Lesage et al., 1994) . It seems unlikely that HBP1 is an inducer of a speci®c dierentiating pathway, given its expression in two distinct lineages. One possibility we favour is that HBP1 acts more broadly at an early stage of dierentiation, perhaps during commitment. Repression of its activation functions by RB and other pocket proteins may therefore be required in order to suppress the commitment to dierentiation when cells are quiescent or arrested in G1. In other words, repression of HBP1 activity may be necessary to prevent the cell from embarking on a dierentiating pathway, which may otherwise be triggered by the cessation of cell proliferation. Although super®cially a dierentiation function for HBP1 seems contradictory to its transformation characteristics, HBP1 may be analogous to a transcription factor such as c-jun which has roles in both proliferation and dierentiation (Angel and Karin, 1991) . We therefore cannot rule out a role for HBP1 in either process. Detailed characterization of the transformation and possible dierentiation features of HBP1 (including the isolation of HBP1 responsive genes) is required to establish which of the biological functions of HBP1 is regulated by the pocket proteins.
We have shown that E1A can repress the transactivation functions of HBP1. Given that E1A is a known suppressor of dierentiation pathways, these results also point to a dierentiation speci®c function for HBP1. Transcriptional repression could be the result of E1A binding a co-activator protein whose function is required to stimulate the HBP1 activation domain. We have shown that the sequestered coactivator is not CBP, which is a protein capable of mediating the activity of numerous other activation domains (Janknecht and Hunter, 1996) . This raises the possibility that the protein sequestered by E1A has a more speci®c role, such as in dierentiation. Recently, E1A has been shown to possess residues within CR1 (distinct from the RB and CBP binding sites) which are required for the repression of skeletal muscle speci®c enhancers (SandmoÈ ller et al., 1996) . A protein which binds such residues may have the characteristics expected for a transcriptional co-activator of HBP1.
The HBP1 transcription factor represents the ®rst characterized target of the pocket family, other than E2F, whose activation functions are repressed by this family. Biologically HBP1 may be involved in the process of cell proliferation as well as dierentiation. Such apparently diverse functions may explain the need for the tight regulation of HBP1 activity by inhibitor domains. Thus, signals which unmask the activation capacity of HBP1 may regulate the dierent functions associated with it. 
Materials and methods

Yeast two-hybrid system
Components of the yeast two-hybrid system were provided by S Hollenberg. The bait was constructed by insertion of the pocket domain of p130 (amino acids 322 ± 1070, gift from P Whyte) into the Lex A fusion vector pBTM116 (Bartel and Fields, unpublished) . The library screened was mouse embryonic cDNA prepared from 9.5/10.5 d.p.c. CD1 mouse embryos ligated into pVP16. Interaction assays were carried out in yeast strain L40 as described (Vojtek et al., 1993; S Hollenberg, personal communication) . 6610 8 primary transformants were screened and grown on ± THULL plates in the presence of 3 mM 3-aminotriazole. After 3 days, 110 colonies had grown, these yeast were further cultured and library plasmids isolated by standard procedures. Sequence tags were obtained using United States Biochemicals Sequenase V 2.0 kits.
Cell cultures, transfections, CAT assays and retroviral infection
U2OS human osteosarcoma cells, BOSC23 and NIH3T3 were maintained in DMEM supplemented with 10% fetal calf serum and grown at 378C (5% CO 2 ) as monolayers and split 1 : 4 every 3 days. For transfection of U2OS, *2.5610
8 cells were seeded 6 h prior to the procedure. Transfection was performed by the calcium phosphate coprecipitation technique. DNA was left on the cells for 14 h before washing, cells were harvested 36 h after transfection. Extracts from transfected cells were then used for CAT assays and for Western blots, using a GAL4 DBD speci®c antibody to check for expression of transfected proteins. The retroviral packaging cell line BOSC 23 was transfected with 30 mg of pBabe (puro) or pBabe (puro) HBP-1 plasmids by calcium phosphate co-precipitation as described by Pear et al., 1993) . Medium containing the retrovirus was harvested 24 h following removal of the precipitate and used to infect NIH3T3 cells at 30% con¯uency. Uncloned pools of puromycin resistant cells were generated and maintained as described by Xu et al. (1995) , except that cells growing in the supernatant were kept each time and reseeded when NIHpBabe or NIHHBP cells were split.
In vivo expression plasmids
For the Ga14 fusion experiments, various domains of HBP-1 were cloned into pHKGT (Hagemeier and Kouzarides, unpublished) using PCR or inherent restriction sites. pHKGT has the GAL4(1 ± 147) DBD under the control of an SV40 promoter. The reporter construct for Ga14-fusions was G5E1b.CAT a gift from M Green. Control plasmids were Ga14.p53(1 ± 73) (Martin and Kouzarides, unpublished) and Ga14.mSry(138 ± 395), a gift from R Dubin. Pocket proteins were expressed under the control of the cytomegalovirus promoter and were gifts from W Kaelin (Rb: amino acids 379 ± 928 and RbD22); K Helin (p107); and P Whyte (p130). The Ad5 E1A 12S and E1A DCR1 and DCR2 were expressed from pBJ9O, gifts from H Land. E1A p300 and Rb mutants and the p300.Rb double mutant were reported previously (Trouche and . An HA-tagged expression vector, pCMV 5'2N3T was constructed by replacing the SV40 promoter of pHK (Hagemeier and Kouzarides, unpublished) with the cytomegalovirus promoter, then inserting two nuclear localization signals and three HA epitope tags at the 5' end of a multiple cloning site. For transformation assays an HA-tagged version of HBP-1 was cloned into pBabe (puro), a gift from H Land, and expressed under the control of the murine Moloney Leukaemia Virus promoter.
GST fusion proteins and pull-down assay
Various domains of HBP-1 were cloned into the relevant pGex vector (Pharmacia), using PCR or inherent restriction sites. Oligonucleotide directed mutagenesis was used to generate mutants. Recombinant proteins were expressed in, and puri®ed from, E. coli as reported previously (Bannister et al., 1991) . Pull-down assays were performed as described previously (Hagemeier et al., 1994) .
In vitro translation of proteins
The pocket domain of pRb (amino acids 379 ± 928) was expressed from pING 14, an SP6 transcription vector (S Inglis, unpublished results). In vitro translation products were generated using the TNT coupled transcriptiontranslation system (Promega) following manufacturers instructions.
Coimmunoprecipitation of Rb and HBP-1 proteins
Approximately 1610
8 U2OS human osteosarcoma cells were transfected with pCMV Rb (379 ± 928) and pCMV 5'2N3T HBP-1(11 ± 394) as described above. Thirty-six hours after transfection cells were harvested by scraping into PBS, pelleted then lysed by rotation in EBC buer containing 200 mM NaCl as described (Hagemeier et al., 1994) . Immunoprecipitations were carried out using an anti RB monoclonal antibody (G3-245, Pharmingen) or anticyclin B2 antibody (gift from J Pines) in the presence of protein G-Sepharose and protein A-agarose (Sigma). Precipitates were washed ®ve times in NETN buer as described (Hagemeier et al., 1994) , separated by SDS ± PAGE and blotted onto nitrocellulose. Western blotting was performed with anti-HA monoclonal antibody (12CA5, Boehringer). Immunoreactive bands were revealed using an ECL kit (Amersham) according to the manufacturers instructions.
